Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-08
DOI
10.1111/1346-8138.14997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
- (2018) Caitriona Ryan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study
- (2018) J.H. Lee et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hidradenitis Suppurativa
- (2017) Ditte Marie Lindhardt Saunte et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 026 Nationwide investigation of hidradenitis suppurativa in Japan
- (2017) K. Hayama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genetic analysis ofNCSTNfor potential association with hidradenitis suppurativa in familial and nonfamilial patients
- (2016) M. Liu et al. BRITISH JOURNAL OF DERMATOLOGY
- The Genetics of Hidradenitis Suppurativa
- (2016) John R. Ingram DERMATOLOGIC CLINICS
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
- (2015) Christos C. Zouboulis et al. DERMATOLOGY
- Questionnaire surveillance of hidradenitis suppurativa in Japan
- (2015) Ichiro Kurokawa et al. JOURNAL OF DERMATOLOGY
- Hidradenitis suppurativa: Epidemiology and scope of the problem
- (2015) Gregor B.E. Jemec et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
- (2015) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hidradenitis suppurativa
- (2014) Lynette J. Margesson et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Ethnicity and Hidradenitis Suppurativa
- (2014) Virginia J. Reeder et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
- (2012) Benjamin G. Vazquez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study
- (2012) Florence Canoui-Poitrine et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- What causes hidradenitis suppurativa?
- (2009) Lübeck Ralf Paus et al. EXPERIMENTAL DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More